Zydus ties up with Synthon BV for multiple sclerosis drug launch in US
Zydus Lifesciences on Thursday said its subsidiary has joined hands with the Netherlands-based Synthon BV to introduce a generic drug for the treatment of multiple sclerosis in the US market.Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Synthon BV for Ozanimod capsules (a generic version of ZEPOSIA) for the…